About Dr. Rejiv Rajendranath

Dr. Rejiv Rajendranath is a highly distinguished and award-winning Medical Oncologist, recognised for his profound expertise and compassionate, patient-centric approach. With over a decade of dedicated experience, he has established himself as one of the leading medical oncologists in India, particularly known for his work in Breast, Gynaecological, and Geriatric Oncology. As a top oncologist in India, Dr. Rajendranath combines a strong academic background, including a professorship at the prestigious Cancer Institute (WIA), Adyar, with extensive clinical practice. He is a prolific researcher and is celebrated for his commitment to providing personalised care, leveraging the latest advancements in chemotherapy, targeted therapy, and immunotherapy to achieve the best possible outcomes for his patients.

Medical Degrees
  • MBBS: Kasturba Medical College (KMC), Mangalore (1998)
  • MD (General Medicine): Kasturba Medical College (KMC), Mangalore (2002)
  • DM (Medical Oncology): Cancer Institute (WIA), Adyar, Chennai (2007)
  • DNB (Medical Oncology): National Board of Examinations (2008)
Fellowships & Special Training
  • Preceptorship in Chronic Myeloid Leukaemia (CML): One-month programme at Royal Adelaide Hospital, Australia, under Professor Tim Hughes (International CML Foundation).
Certifications & Accreditations
  • ECMO Certified: European Society for Medical Oncology (ESMO)
  • Member of the Indian Medical Association (IMA)

Major Cancer Types Treated
  • Breast Cancer
  • Gynaecological Cancers (Ovarian, Uterine, Cervical)
  • Gastrointestinal (GI) Cancers (Colorectal, Stomach, Pancreatic)
  • Genitourinary (GU) Cancers (Prostate, Kidney, Bladder)
  • Head and Neck Cancers
  • Lymphoma
  • Lung Cancer
  • Chronic Myeloid Leukaemia (CML)
Sub-specialties
  • Breast Oncology
  • Gynaecological Oncology
  • Gastrointestinal & Genitourinary Oncology
  • Geriatric Oncology
Advanced Procedures Performed
  • Chemotherapy (latest regimens)
  • Targeted Therapy
  • Immunotherapy
  • Hormonal Therapy
  • Management of complex and metastatic cancers
  • Personalised cancer treatment based on molecular profiling

Current & Past Hospital Affiliations
  • Senior Consultant, Medical Oncology, Apollo Cancer Centre, Chennai (Current)
  • Honorary Consultant, Medical Oncology, Southern Railway Headquarters Hospital
Academic & Research Roles
  • Professor & Teaching Faculty: Mentored postgraduate medical oncology students at the Cancer Institute (WIA), Adyar.
  • Examiner for DM (Medical Oncology): Appointed by Tamil Nadu Dr. M.G.R. Medical University.
  • Prolific Researcher: Authored and co-authored over 54 publications in prestigious peer-reviewed national and international journals.
  • Project Member: Participated in the "Health Systems Research" project led by the World Health Organisation (WHO).
Key Achievements & Contributions
  • An ESMO-certified oncologist, signifying adherence to the highest European standards of cancer care.
  • Recognised for his significant research contributions, especially on breast cancer in young women and geriatric oncology.
  • Has played a key role in shaping oncology education in India as a professor and examiner.

  • Best Doctor Award (2011): Conferred by the Tamil Nadu Dr. M.G.R. Medical University for his contributions to Medical Science.
  • Dr. K. S. Sanjivi Award (2013): For outstanding and selfless voluntary medical service to the poor and needy.
  • Best Paper Award (2011): At the National Indian Society of Oncology Biennial Meeting.
  • Best Paper Award (2009): For his paper on "Breast cancer in Young women less than 30 years from Southern India" at ONCOCON 2009.

  • Dr. Rajendranath is a distinguished academician with over 54 publications. His research focuses on improving treatment outcomes and understanding cancer demographics in India.
Selected Publications:
  • Setting Up Geriatric Oncology Clinical Services: Asian Geriatric Oncology Society Guidelines 2025 (Part 1), Journal TBC (2025)
  • Ovarian Germ Cell Tumours: Cancer Institute (WIA), Adyar Experience over 10 years including QOL Data, Journal of Ovarian Research (2022)
  • [Experts' Opinion] Novel formulations of docetaxel, paclitaxel and doxorubicin in the management of metastatic breast cancer, Indian Journal of Cancer (2018)
  • Outcomes in Lung Cancer: 9-Year Experience From a Tertiary Cancer Center in India, Journal of Global Oncology (2017)
  • Phase II study of Interim PET-CT guided response adapted therapy in advanced Hodgkin's lymphoma, Annals of Hematology (2015)
  • Acute lymphoblastic leukemia: A single center experience with Berlin, Frankfurt, and Munster-95 protocol, Indian Journal of Medical and Paediatric Oncology (2015)

  • Notable Cases Handled: Dr. Rajendranath is known for his expertise in managing complex, metastatic breast and gynaecological cancer cases with personalised treatment plans. His work in geriatric oncology has enabled many elderly patients to receive effective cancer treatment with tailored doses and supportive care, significantly improving their quality of life.
Patient Testimonials
  • "When my mother was diagnosed with ovarian cancer, we were shattered. Dr. Rejiv Rajendranath was our ray of hope. He treated her not just as a patient, but as a person. His detailed explanations and evidence-based approach gave us immense confidence. Today, she is in remission and living a full life." - Priya K.
  • "I was diagnosed with an aggressive form of breast cancer. Dr. Rejiv's protocol of targeted therapy combined with chemotherapy was a game-changer. He is always accessible, patient, and incredibly knowledgeable. I believe I am in the hands of one of the best medical oncologists in India." - Aisha B.
  • "As an elderly patient with lymphoma, I was worried about the side effects of chemotherapy. Dr. Rajendranath designed a special geriatric-friendly regimen for me. His focus on maintaining my quality of life was remarkable. I tolerated the treatment well, and I am grateful for his exceptional care." - Raju B.

  • Patient-Centred Care: Dr. Rajendranath firmly believes in a holistic and patient-centric model of care. He is dedicated to understanding each patient's unique medical, social, and emotional needs. He empowers his patients by educating them about their condition and treatment options, fostering a collaborative environment where informed decisions are made together.
  • Technology & Innovation: An academic at heart, Dr. Rajendranath is committed to staying at the forefront of oncological advancements. He integrates the latest evidence from clinical trials and research into his daily practice, utilising novel drug formulations, targeted agents, and immunotherapy to offer state-of-the-art, personalised cancer care.

For the consultation fee, you can connect with the Cancer Rounds team. The cost of medical oncology treatment is highly dependent on the type of cancer, the specific drugs used (chemotherapy, targeted therapy, immunotherapy), the number of cycles, and supportive care required.
Treatment TypeEstimated Cost per Cycle in India (INR)Estimated Cost per Cycle in India (USD)
Standard Chemotherapy₹ 30,000 - ₹ 80,000$ 360 - $ 960
Targeted Therapy₹ 1,00,000 - ₹ 3,00,000+$ 1,200 - $ 3,600+
Immunotherapy₹ 1,50,000 - ₹ 4,00,000+$ 1,800 - $ 4,800+
Hormonal Therapy (Monthly)₹ 5,000 - ₹ 25,000$ 60 - $ 300
Note: These are indicative costs and can vary significantly based on the specific drug, brand, and duration of treatment. For a detailed treatment plan and cost estimate, please consult with the Cancer Rounds team.

  • Language Support: The Cancer Rounds team ensures that international patients have a seamless experience by providing professional interpreters and coordinators to facilitate clear communication with Dr. Rajendranath and his team.
  • Visa & Travel Assistance: We provide comprehensive support for medical visa processing, travel logistics, airport transfers, and arranging comfortable accommodation for patients and their families during their stay in Chennai.
  • Pre-treatment Virtual Consultations:Dr. Rajendranath is available for pre-travel online consultations to review medical records, provide a detailed second opinion, and outline a potential treatment strategy, allowing patients to plan their trip to India with confidence.

Frequently Asked Questions

Dr. Rejiv Rajendranath is a leading Medical Oncologist in India with special interests in Breast Cancer, Gynaecological Cancers (like ovarian cancer), Gastrointestinal Cancers, and Geriatric Oncology.

His status as a top oncologist in India is supported by his strong academic credentials (Professor at Cancer Institute, Adyar), numerous prestigious awards like the 'Best Doctor Award', and his certification from the European Society for Medical Oncology (ESMO).

Geriatric Oncology is a specialised field focused on treating cancer in older adults (typically over 65). Dr. Rajendranath is an expert in this area, focusing on creating tailored treatment plans that are effective against the cancer while minimising side effects and preserving the patient's quality of life and functional independence.

Yes, he is a very active researcher with more than 50 publications in national and international peer-reviewed journals. His research contributions, especially in breast cancer and geriatric oncology, help shape better treatment guidelines.

He offers the full spectrum of modern medical oncology treatments, including the latest regimens of chemotherapy, targeted therapy, and immunotherapy. His approach involves personalising these treatments based on the tumour's genetic makeup and the patient's overall health.

Being certified by the European Society for Medical Oncology (ESMO) means that Dr. Rajendranath has demonstrated a high level of expertise that meets the rigorous standards of excellence in oncology practice set by one of the world's leading professional oncology organisations.

To schedule an in-person or virtual consultation with Dr. Rajendranath, you can contact the Cancer Rounds team. They will assist you with the entire process, including appointment scheduling and medical record management.